Back to catalogue
№ 056 27 filings · 2021-07-26 → 2026-04-23

BEAZLEY PLC

BEZ
Insurance Share price 1,297p Market cap £7.7bn Overall fit 340 /1000

Well-run specialist insurer trading close to an active takeover bid. Only tangential AI-beneficiary angle (cyber insurance), limited operating leverage, and valuation now bid-supported rather than fundamentally cheap — poor fit for the AI-receiver / operating-leverage strategy despite the quality of the business.

Fair value range 1,150p–1,300p Mid case · £7.3bn
Absolute upside -5.6% vs current market cap
Conviction 3/5 confidence in fair call
Supports the call
  • Consistent combined-ratio guidance track record with 2025 upgrade to low-80s
  • Rule 2.7 offer-period anchoring near-term price to a bid range
  • Peer-multiple triangulation gives defensible standalone valuation
Limits the call
  • Bidder identity, offer price and completion probability not disclosed in filings
  • IFRS 17 transition and USD-report / GBP-list translation add noise
Methodology

Blended forward P/E + takeover-bid anchor, weighted by deal completion

In one line · bull case

High-quality specialist Lloyd's insurer with disciplined underwriting and an active takeover bid supporting the price near recent highs.

In one line · biggest risk

Announced takeover bid failing to complete, which would likely re-rate the shares back toward standalone fundamentals ~15-25% lower.

Drivers
AI beneficiary 25 /100
Cyber insurance is an indirect AI-adjacent beneficiary but Beazley captures spend, doesn't sell into the AI value chain.
Operating leverage 40 /100
Claims and acquisition costs scale with premiums; upside is rate-cycle-driven, not scale-driven.
Earnings vs expectations 72 /100
2025 CR guidance upgraded mid-year; consistent record of meeting/beating profitability guidance.
Growth momentum 48 /100
GWP growth decelerated from double-digits in 2022-23 to flat/low-single-digit in 2025.
Moat 55 /100
Lloyd's franchise, cyber-market leadership and specialist expertise — meaningful but not dominant.
Earnings quality 65 /100
Reserve releases across divisions suggest conservative reserving; investment income cycle-sensitive.
Management quality 70 /100
Active capital management (2024/2025 buybacks, Bermuda platform build), disciplined cycle management.
Cyclicality 60 /100
Underwriting cycle plus catastrophe volatility (Ida/Milton/Helene/CA wildfires) make it moderately cyclical.
Leverage 30 /100
Solvency II ratio target >170%, modest sub-debt, well-capitalised for insurer standards.
Value-trap signals · 2
  • Cyber and property rates declining in 2025 (-6% and -7% YTD)
  • 2025 growth guidance cut within the year from mid-single to flat/low-single digit

Beazley plc (BEZ.L) — Research Note

Executive summary

Beazley is a specialist (re)insurer that manages six Lloyd's syndicates and underwrites Cyber, Specialty (D&O/professional), Property, MAP and Reinsurance risks worldwide, with 2025 gross premiums of ~$6.1bn. Underwriting quality has improved materially across the period — the 2025 undiscounted combined-ratio guide was upgraded to "low 80s" 2025-11 trading update versus mid-80s guided in April 2025-04 trading update, while top-line growth has decelerated from double-digits (2022-23) to "flat to low single digits" as cyber and property rates soften. The single most important valuation point today is that the shares' 63% one-year rally sits on top of a Rule 2.7 Announcement (2 March 2026) referenced in the dividend circular 2026-03-02 dividend declaration and confirmed by mandatory Rule 8 disclosures 2026-04-01 Form 8.3, LMR Partners at $12.67/£12.67 reference price, i.e. Beazley is in an active offer period and the market price is effectively anchored to a takeover bid, not to standalone fundamentals.

Fair value estimate

Range: 1,150p – 1,300p (implied mcap £6,850m – £7,740m). Midpoint 1,225p (£7,295m).

Two components:

  1. Standalone fundamental value (~1,000–1,150p). 2024 GWP was $6,164m and 2025 comparable, with net earned premiums ~$5.0bn and a low-80s combined ratio implying underwriting profit of ~$900m. Add ~$500–600m investment income on the $11.7bn portfolio (4% yield) and finance costs, deduct tax: earnings of ~$1.0-1.2bn ≈ £790–940m. Applied to a 8–10x forward P/E — in line with peers Hiscox and Lancashire — gives ~£6.3–£8.5bn or 1,060–1,430p. Anchoring conservatively at ~10x on a normalised earnings base gives ~1,050p standalone.
  2. Bid-anchored value (~1,270–1,300p). LMR Partners' Form 8.3 references a $12.67 reference price 2026-04-01; the stock traded in a tight 1,266–1,296p band since March 2026, consistent with a firm offer of ~1,275–1,300p.

Weighting these ~40/60 (bid completion probability), fair value midpoint 1,225p vs. current 1,296p implies **-5% downside** if you assume some risk the deal fails or is completed at the lower end.

Methodology: blended forward-earnings multiple + bid-anchor, weighted by deal-completion probability.

Sector context

Insurance (ICB Financials, Non-life Insurance). Beazley's specialist mix (heavy in cyber, D&O, specialty) and Lloyd's platform position it as above the sector average on quality and technical returns, with combined ratio in the low 80s vs. typical UK non-life peers in mid-90s. Balance-sheet leverage is in line. Listed peers: Hiscox (HSX.L), Lancashire Holdings (LRE.L), Conduit Holdings (CRE.L).

Investment thesis (3 bullets)

  1. Underwriting quality is genuinely differentiated. 2025 combined ratio guide upgraded to low 80s 2025-11 trading update; disciplined pricing has been maintained even into softening cyber and property markets. Book has released reserves in prior years, indicating conservative reserving.
  2. Investment portfolio delivers meaningful returns at current rates. $11.7bn portfolio yielding ~4.0% on fixed income with 1.7yr duration 2025-11 trading update contributes ~$500m/year of investment income — recurring, capital-light earnings that support the dividend.
  3. Bid support caps downside near-term. The 2 March 2026 Rule 2.7 Announcement (referenced by the "Permitted Dividend" wording 2026-03-02 dividend declaration) and the tight trading band around ~1,270–1,296p suggest a firm bid provides a floor at recent levels.

Key risks (3 bullets)

  1. Deal risk / bid failure. If the announced offer collapses (not-disclosed-but-inferred from the 2.7 reference), shares could rerate back to standalone fundamentals ~1,000–1,100p — a 15–25% drawdown from current.
  2. Cyber pricing erosion. North America cyber rates have declined "since 2022 despite increasing frequency and severity of ransomware claims" 2025-11 trading update. Cyber accounts for ~18% of GWP; further margin compression here would hit group profitability.
  3. Nat-cat and long-tail volatility. The book carries meaningful catastrophe exposure (2024 Hurricane Helene/Milton net loss $125–175m 2024-11 trading update; California wildfires 2025 $80m 2025-04 trading update) and social-inflation exposure in specialty/healthcare lines that could produce reserve strengthening.

Operating leverage

Beazley has limited genuine operating leverage in the sense the investor profile seeks. Claims and acquisition costs scale with premiums (variable), and the expense ratio has been broadly stable in the 36–37% range even as GWP has grown from $4.6bn (2021) to $6.1bn (2025). What operating leverage exists is at the investment-income line: a $11.7bn float earning ~4% versus ~1% pre-2022 has driven the majority of the earnings step-up — that's rate-cycle leverage, not scale leverage. The new $500m Bermuda platform investment 2025-11 trading update is a capacity/geographic expansion, not fixed-cost leverage. A 10–20% revenue upside would probably lift operating profit ~15–25%, not multiples — this is a moderate-leverage business, not the "long-tail of outcomes" profile the strategy prizes.

Value-trap signals

  • Rate declines across cyber (-6% YTD) and property (-7% YTD) 2025-11 trading update suggest the underwriting cycle is softening.
  • Growth guidance downgraded within 2025 from mid-single digits to "flat to low single digits" 2025-11 vs 2025-04 trading updates.
  • Otherwise, no structural value-trap signals: dividend growing, strong Solvency II ratio (>170% target), consistent reserve releases, buybacks in 2024 and 2025.

Earnings vs. expectations

Filings don't include quarterly consensus/actual comparisons, but the guidance-vs-delivery track record is strong: 2023 low-80s guide was delivered 2023-11 trading update; 2024 "around 80%" undiscounted CR maintained through active hurricane season 2024-11 trading update; 2025 CR guide was upgraded mid-year from mid-80s to low-80s 2025-11 trading update. Growth guidance was downgraded within 2025 (mid-single → flat/low-single). Pattern: beats on profitability, misses on volume when discipline demands it — a favourable pattern for quality-focused investors.

Conviction

Conviction: 3 (moderate). Anchors: (i) the Rule 2.7 Announcement makes the near-term price a policy variable, not a valuation variable; (ii) disclosure is clean and combined-ratio guidance has been reliable; (iii) peer multiples give a defensible standalone valuation range. Limits: (i) the filings do not disclose the identity, price or structure of the bidder, so the deal-completion probability is a judgement; (ii) IFRS 17 transition and the mix of USD reporting / GBP listing add translation noise to the earnings picture.

Driver scoring rationale

  • AI beneficiary (25): Cyber insurance sees higher demand as AI expands the attack surface, but Beazley is a buyer of AI tooling, not a seller into the AI stack. Not a picks-and-shovels play.
  • Operating leverage (40): Insurance costs scale with premiums; investment-income kicker is cycle-driven, not scale-driven.
  • Earnings surprise (72): Consistent CR beats/upgrades; disciplined miss on top-line rather than accepting bad business.
  • Cyclicality (60): Underwriting cycle + cat exposure make this moderately cyclical.
  • Moat (55): Lloyd's platform, cyber-market leadership, specialist expertise; not a dominant network effect.
  • Leverage (30): Well-capitalised, sub-debt manageable, Solvency II >170%.
  • Earnings quality (65): Reserve releases indicate conservatism; investment-income sensitive to rates.
  • Management quality (70): Active capital return, disciplined underwriting, cycle awareness.
  • Growth momentum (48): Guidance being cut through 2025; growth decelerating.
Filings consulted · 30

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-04-23Result OF Agm2026-04-23_9534808_result-of-agm.md0.30
  2. 2026-04-01Form 8 3 Beazley Plc Amendment Replacing 8788y2026-04-01_9503748_form-8-3-beazley-plc-amendment-replacing-8788y.md0.70
  3. 2026-03-17Notice OF Agm2026-03-17_9478806_notice-of-agm.md0.30
  4. 2026-03-02Dividend Declaration2026-03-02_9454313_dividend-declaration.md0.30
  5. 2025-11-25Trading Statement2025-11-25_9254596_trading-statement.md0.72
  6. 2025-10-06Notice OF Trading Statement Amp Capital Markets Day2025-10-06_9153333_notice-of-trading-statement-amp-capital-markets-day.md0.81
  7. 2025-04-29Trading Statement2025-04-29_8850460_trading-statement.md0.55
  8. 2025-04-22Result OF Agm2025-04-22_8840340_result-of-agm.md0.20
  9. 2025-03-17Notice OF Agm2025-03-17_8783251_notice-of-agm.md0.20
  10. 2024-11-06Trading Statement2024-11-06_8532061_trading-statement.md0.55
  11. 2024-04-29Trading Statement2024-04-29_8160662_trading-statement.md0.38
  12. 2024-04-25Result OF Agm2024-04-25_8157836_result-of-agm.md0.14
  13. 2024-03-20Notice OF Agm2024-03-20_8098505_notice-of-agm.md0.14
  14. 2023-11-30Capital Markets Day Presentation2023-11-30_7913659_capital-markets-day-presentation.md0.43
  15. 2023-11-07Trading Statement2023-11-07_7864216_trading-statement.md0.38
  16. 2023-11-07Notice OF Capital Markets Day2023-11-07_7865680_notice-of-capital-markets-day.md0.43
  17. 2023-07-27Trading Statement For Six Months TO 30 June 20232023-07-27_7657778_trading-statement-for-six-months-to-30-june-2023.md0.21
  18. 2023-05-12Trading Statement2023-05-12_7523984_trading-statement.md0.21
  19. 2023-04-25Result OF Agm2023-04-25_4196_result-of-agm.md0.07
  20. 2023-03-20Notice OF Agm2023-03-20_7479495_notice-of-agm.md0.07
  21. 2022-11-16Beazley Plc Results OF Placing2022-11-16_7374256_beazley-plc-results-of-placing.md0.17
  22. 2022-11-15Beazley Plc Proposed Placing OF Ordinary Shares2022-11-15_7374001_beazley-plc-proposed-placing-of-ordinary-shares.md0.17
  23. 2022-11-11Trading Statement2022-11-11_7336809_trading-statement.md0.21
  24. 2022-05-18Capital Markets Day Presentation2022-05-18_6930878_capital-markets-day-presentation.md0.24
  25. 2022-05-12Notice OF Capital Markets Day2022-05-12_6840604_notice-of-capital-markets-day.md0.24
  26. 2022-05-06Trading Statement2022-05-06_7195041_trading-statement.md0.21
  27. 2022-03-25Result OF Agm2022-03-25_7056500_result-of-agm.md0.07
  28. 2022-02-23Notice OF Agm2022-02-23_6925949_notice-of-agm.md0.07
  29. 2021-11-05Trading Statement2021-11-05_6661569_trading-statement.md0.21
  30. 2021-07-26Correction Interim Results2021-07-26_6742426_correction-interim-results.md0.09

This research note was authored by a large language model after reading 27 regulatory filings published between 2021-07-26 and 2026-04-23. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.